Overview

Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol

Status:
COMPLETED
Trial end date:
2011-07-04
Target enrollment:
Participant gender:
Summary
Pharmacokinetics, pharmacological effects and safety of single dose of 7.5mg Tolvaptan tablet in healthy male subjects
Phase:
PHASE1
Details
Lead Sponsor:
Otsuka Beijing Research Institute
Treatments:
Tolvaptan